Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Zymeworks Catalyst Calendar
Proactively evaluate Zymeworks Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of Zymeworks Catalyst Calendar data
Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
---|---|---|---|---|---|---|---|
01 Dec 2021 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
15 Oct 2021 | Phase II Trial Initiation | University of Texas MD Anderson Cancer Center; Zymeworks Inc | ZYME | zanidatamab | Oncology | Breast Cancer; Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer) | Clinical Trial Registry |
16 Sep 2021 | Phase II Trial Results | Sarah Cannon Research Institute LLC; Zymeworks Inc | ZYME | zanidatamab | Oncology | Adenocarcinoma Of The Gastroesophageal Junction; Bile Duct Cancer (Cholangiocarcinoma) ; Colorectal Cancer; Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Gastric Cancer; Gastroesophageal (GE) Junction Carcinomas; Gastrointestinal Tumor | Company Press Release |
01 Dec 2020 | Phase II Trial Initiation | Pfizer Inc; PPD Inc; Sarah Cannon Research Institute LLC; Zymeworks Inc | PFE; ZYME | zanidatamab | Oncology | Breast Cancer; Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer); Metastatic Breast Cancer | Clinical Trial Registry |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer